Hansa Medical and Axis-Shield report most promising results from pivotal clinical trial with HBP-analysis
The clinical study was carried out at Emergency Departments both in Sweden and the US through 2011-2013. Results show that HBP-analysis predicts patients with forthcoming severe inflammatory response to infection (severe sepsis) with significantly higher accuracy than any of the other methods tested. Data will be presented at the 6th Annual Symposium of the International Sepsis Forum in Rio de Janeiro, Brazil, on November 5, 2013.Background to the studyHBP-analysis is a novel method developed by Hansa Medical to help predict severe sepsis at Emergency Departments (ED). Hundreds of